Protective efficacy of a fully recombinant plague vaccine in the guinea pig

Vaccine

Volumn 21, Issue 25-26, 2003, Pages 3912-3918

  Jones, S M ^a,b   Griffin, K F ^a   Hodgson, I ^a   Williamson, E D ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Guinea pig; Passive immunisation of mouse; Protective efficacy; Recombinant plague vaccine; rF1+rV

Indexed keywords

BACTERIAL ANTIGEN; IMMUNOGLOBULIN G; PLAGUE VACCINE; RECOMBINANT VACCINE;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BACTERIAL VIRULENCE; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; FEMALE; GUINEA PIG; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PLAGUE; PRIORITY JOURNAL; PROTEIN PURIFICATION; REDUCTION; YERSINIA PESTIS;

EID: 0242349121     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00379-7     Document Type: Article

References (30)

1. Perry R.D., Fetherston J.D. Yersinia pestis - etiologic agent of plague. Clin. Microbiol. Rev. 10(1):1997;35-66.
2. Meyer K.F. Effectiveness of live or killed plague vaccines in man. Bull. WHO. 42:1970;653-666.
3. Bartelloni P.J., Marshall J.D., Cavaugh D.C. Jr. Clinical and serological responses to plague vaccine U.S.P. Mill. Med. 138:1973;720-722.
4. Williams J.E., Altieri P.L., Berman S., Lowenthal J.P., Cavanaugh D.C. Potency of killed plague vaccines prepared from avirulent Yersinia pestis. Bull. WHO. 58:1980;753-756.
5. Meyer K.F., Smith G., Foster L.E., Marshall J.D., Cavanaugh D.C. Plague immunization. IV. Clinical reactions and serological responses to inoculations of Haffkine and freeze-dried plague vaccine. J. Infect. Dis. 129(Suppl.):1974;S30-S36.
6. von Metz E., Eisler D.M., Hottle G.A. Immunogenicity of plague vaccines in mice and guinea pigs. Appl. Microbiol. 22:1971;84-88.
7. Marshall J.D., Bartelloni P.J., Cavanaugh D.C., Kadull P.J., Meyer K.F. Plague immunisation. II Relation of adverse clinical reactions to multiple immunisations with killed vaccine. J. Infect. Dis. 129(Suppl.):1974;S19-S25.
8. Andrews G.P., Heath D.G., Anderson G.W. Jr., Welkos S.L., Friedlander A.M. Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and an Escherichia coli recombinant strain and efficacy against lethal plague challenge. Infect. Immun. 64:1996;2180-2187.
9. Anderson G.W., Leary S.E.C., Williamson E.D.et al. Recombinant V antigen protects mice against pnuemonic and bubonic plague against F1 positive and negative strains of Y. pestis. Infect. Immun. 63:1995;2854-2858.
10. Speck R.S., Wolochow H. Studies on the experimental epidemiology of respiratory infections. VIII. Experimental pneumonic plague in Macacus rhesus. J. Infect. Dis. 100:1957;58-69.
11. Williamson E.D., Eley S.M., Stagg A.J., Green M., Russell P., Titball R.W. A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunised animals against pneumonic plague. Vaccine. 15:1997;1079-1084.
12. Anderson G.W., Heath D.G., Bolt C.R., Welkos S.L., Friedlander A.M. Short and long term efficacy of single dose subunit vaccines against Yersinia pestis in mice. Am. J. Trop. Med. Hyg. 58:1998;793-799.
13. Williamson E.D., Eley S.M., Griffin K.F.et al. A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol. Med. Microbiol. 12:1995;223-230.
14. Williamson E.D., Vessey P.M., Gillhespy K.J., Eley S.M., Green M., Titball R.W. An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model. Clin. Exp. Immunol. 116:1999;107-114.
15. Williams J.E., Arntzen L., Tyndal G.L., Issacson M. Application of enzyme immunoassays for the confirmation of clinically suspect plague in Namibia. Bull. WHO. 64:1982;745-752.
16. Titball R.W., Howells A.M., Oyston P.C.F., Williamson E.D. Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plague. Infect. Immun. 65:1997;1926-1930.
17. 2+-response genes. J. Bacteriol. 173:1991;2649-2657.
18. Une T., Brubaker R.R. Roles of V antigen in promoting virulence and immunity in yersiniae. J. Immunol. 133:1984;2226-2230.
19. Nakajima R., Brubaker R.R. Association between virulence of Yersinia pestis and suppression of gamma interferon and tumour necrosis factor alpha. Infect. Immun. 61:1993;23-31.
20. Pettersson J., Holmström A., Hill J.et al. The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation. Mol. Microbiol. 32:1999;961-976.
21. Lawton W.D., Erdman R.L., Surgalla M.J. Biosynthesis and purification of V and W antigens in Pasteurella pestis. J. Immunol. 91:1963;179-184.
22. Leary S.E.C., Williamson E.D., Griffin K.F., Russell P., Eley S.M., Titball R.W. Active immunisation with recombinant V antigen from Yersinia pestis protects mice against plague. Infect. Immun. 63:1995;2854-2858.
23. Jones S.M., Day F., Stagg A.J., Williamson E.D. Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains. Vaccine. 19:2000;358-366.
24. Miller J., Williamson E.D., Lakey J.H., Pearce M.J., Jones S.M., Titball R.W. Macromolecular organisation of recombinant Yersinia pestis F1 antigen and the effect of structure on immunogenicity. FEMS Immunol. Med. Microbiol. 21:1998;213-221.
25. Russell P., Eley S.M., Hibbs S.E., Manchee R.J.A.J., Titball R.W. A comparison of plague USP and EV76 Vaccine induced protection against Yersinia pestis in a murine model. Vaccine. 13:1995;1551-1556.
26. Politzer R. Plague. WHO Monogr. Ser. 22:1954;1-698.
27. Wayson N.E., McMahon C., Prince F.M. An evaluation of three plague vaccines against infection in guinea pigs induced by natural and artificial methods. Public Health Rep. 36:1946;357-358.
28. Jawetz E., Meyer K.F. The behaviour of virulent and avirulent P. pestis in normal and immune experimental animals. J. Infect. Dis. 74:1944;1-13.
29. Poland JD, Barnes AM. Plague. In: Steele JH, editor. CRC handbook series in zoonoses. Section A. Bacterial, ricketsial, chlamydial and mycotic. 2nd ed. Boca Raton (FL): CRC Press; 1979. p. 515-59.
30. Spivack M.L., Foster L., Larson A., Chen T.H., Baker E.E., Meyer K.F. The immune response of the guinea pig to the antigens of Pasteurella pestis. J. Immunol. 80:1958;132-141.